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STATE METHAMPHETAMINE PRECURSOR POLICIES AND 
CHANGES IN SMALL TOXIC LAB METHAMPHETAMINE 
PRODUCTION
DUANE C. MCBRIDE, YVONNE M. TERRY-MCELRATH, JAMIE F. CHRIQUI, JEAN C. 
O’CONNOR, CURTIS J. VANDERWAAL, KAREN L. MATTSON
Domestic production of methamphetamine in small toxic labs (STLs) results in 
signifi cant community safety and health consequences. This paper examines the 
effects of state-level policies implemented in the middle of the last decade in reaction 
to a rapid increase in STL labs. These policies focused on controlling access to 
the methamphetamine precursor chemicals ephedrine and pseudoephedrine and 
the relationship of such policies with actual STL seizure rates. Data include (a) 
primary legal research on state laws/regulations in all 50 states in effect as of 
October 1, 2005; and (b) STL seizure counts for 2004–2006. Results from random 
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effects cross-sectional time-series regression models showed that states with the 
greatest reduction in STL seizures had comprehensive policies involving quantity 
limits on methamphetamine precursor purchases, clerk intervention requirements 
(such as requiring buyer identifi cation) and regulatory agency specifi cation for 
monitoring compliance and tracking multiple purchases. Criminalizing purchasing 
violations was not related to STL reductions. 
INTRODUCTION
Research suggests that methamphetamine use relates to high risks of addiction 
and abuse (Anglin, Burke, Perrochet, Stamper, & Dawud-Noursi, 2000; Baucum, 
Rau, Riddle, Hanson, & Fleckenstein, 2004; National Institute on Drug Abuse 
[NIDA], 2006; Volkow et al., 2001), as well as sustained and increased general 
and violent criminal behavior (Cartier, Farabee, & Prendergast, 2006; Hansell, 
2006; Sommers, Baskin, & Baskin-Sommers, 2006). Methamphetamine use has 
signifi cant consequences for community safety and health, including increased 
levels of community violence (Kyle & Hansell, 2005) as well as increased risk 
of child neglect and abuse (Dube et al., 2003; Mecham & Melini, 2002) and 
associated removal of children from homes (Hansell, 2006; Kyle & Hansell, 2005). 
The production of methamphetamine has also proven to have signifi cant public 
health consequences to communities, especially when produced in small toxic 
labs (STL). STL methamphetamine production combines key precursor chemicals 
such as pseudoephedrine and ephedrine (found in common cold medications) with 
hazardous and often volatile acids, solvents, metals or salts. STLs are generally 
defi ned as laboratories that produce one pound or less of methamphetamine per 
cooking cycle, and were estimated to provide approximately 20 percent of the United 
States (US) methamphetamine supply in 2006 (O’Connor, Chriqui, & McBride, 
2006). Explosives are sometimes planted around STLs to protect the production 
unit, and violence is likely to be directed at law enforcement personnel who seize 
the lab (Scott & Dedel, 2006). 
STL methamphetamine production often occurs in home environments where 
signifi cant health consequences related to direct toxic chemical exposure and 
related fumes occur. Exposure can result in chemical burns and damage to the 
respiratory system as well as a wide variety of neurological and other health-related 
consequences for those who live in the environment, with children being particularly 
vulnerable to serious harms (Barr et al., 2006; Farst et al., 2007). Rates of child 
abuse and neglect are also heightened in STL environments. It is important to note 
that these health consequences can continue to affect the next residents of the home 
who may not be aware that methamphetamine was produced in the structure they 
buy or rent. 
First responders (law enforcement, fi refi ghters, emergency medical personnel, 
etc.) who participate in an STL seizure or respond to an explosion or fi re at a 
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lab also are at high risk from the toxic compounds used in and resulting from 
methamphetamine production (Cooper et al., 2000; McFadden, Kub, & Fitzgerald, 
2006). Further, there are continuing health consequences from contamination of 
the broader environment including soil, ground water, and any other material in or 
near the production site. Environmental contamination can result in long-term, on-
going health consequences for those who come into contact with the contaminated 
environment and considerable local costs related to necessary clean-up efforts 
(Royal Canadian Mounted Police, 2001). Dobkin and Nicosia (2009) published 
a report summarizing methamphetamine production cost estimates in the US for 
2005; they noted that methamphetamine production and use has market costs and 
consequences similar to those for other illegal drugs. However, methamphetamine 
has additional costs of toxic chemicals present in the production environment that 
result in considerable health and safety risks. Overall, their best estimate of costs 
in 2005 was $23,384,400.
Data from the Drug Enforcement Agency’s national Clandestine Laboratory 
Seizure System (CLSS) documented a large increase in the number of US 
methamphetamine STLs in the early 2000s as such labs spread quickly from West to 
East. The CLSS reported 6,777 methamphetamine STL seizures in 1999, increasing 
to 8,577 in 2001 and 10,015 in 2004 (National Drug Intelligence Center [NDIC], 
2005; 2006). Given the widespread geographic increase in the distribution of STLs 
in the early 2000s and the consequences of domestic methamphetamine production 
and use, states and the federal government undertook major efforts to restrict access 
to over-the-counter medications and other products that contain methamphetamine 
chemical precursors. 
O’Connor and her colleagues (O’Connor, Chriqui, & McBride, 2006; O’Connor 
et al., 2007) documented the wide variety of policy approaches taken by states to 
restrict access to methamphetamine precursor products. Anecdotal reports and 
congressional testimony indicated that signifi cant decreases in STL seizures followed 
the enactment of these precursor policies (Offi ce of National Drug Control Policy 
[ONDCP], 2006; Rutledge, 2004; Wright, 2004). However, there has not been a 
comprehensive multi-state quantitative analysis relating enacted state legislation 
or adopted regulations (hereafter referred to as state policies) with STL seizure 
rates. The current paper aims to contribute to the literature by investigating two 
primary research questions. First, is there evidence that STL seizure rates decreased 
signifi cantly following state and federal policy changes implemented between 
January 2004 and October 1, 2005? Second, is there evidence that differences 
exist between states in the relative effectiveness of specifi c precursor policy 
environment? This time period, immediately after the implementation of major 
varying comprehensive policies in many states provided a unique opportunity to 
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examine changes in STL seizures related to specifi c policy elements as well as 
changes in states that did not implement these types of policies.
METHODS
DATA SOURCES
Two main data sources were used: (1) state policies related to methamphetamine 
precursors in effect as of October 1, 2005; and (2) methamphetamine-related STL 
seizure data from 2004-2006.
STATE POLICY DATA
 State methamphetamine precursor policies (including statutory and administrative 
laws) in effect as of October 1, 2005, were obtained by The MayaTech Corporation 
from Westlaw and state government websites using primary legal research methods 
(Mersky & Dunn, 2002). A detailed description of the state methamphetamine 
precursor policy data including data collection methodology can be found elsewhere 
(O’Connor et al., 2007). The October 1, 2005 reference date was chosen to allow 
for pre-/post-analyses linking the state policy data with the STL seizure data for 
2004 and 2006. Due to resource limitations, we were only able to capture one state 
policy reference date. The October 1, 2005 date was chosen as it allowed for at least 
one year of post-implementation-related STL seizure data and at least one year of 
pre-implementation data in states without such policies prior to this date. Although 
not ideal from a policy “lagged” effect perspective, one year of post-policy seizure 
data was considered to be suitable for this study given available anecdotal and 
documented information from the fi eld describing an almost immediate impact of 
precursor policies on reductions in STL seizures (ONDCP, 2006; Rutledge, 2004; 
VanderWaal et al., 2008; Wright, 2004). 
State-specifi c effective dates for all policies were obtained as part of the policy 
data collection process. In other words, although policy data refl ected laws in effect 
as of October 1, 2005, individual policy provisions identifi ed the specifi c effective 
dates when the provisions became effective (see Appendix A for state citations and 
effective dates). The provision-level effective dates enabled the pre/post policy 
analyses described below.
STL SEIZURE DATA
Methamphetamine-related STL seizure data for all states from 2004-2006 were 
obtained from the CLSS housed at the El Paso Intelligence Center (EPIC). CLSS 
data are based on a voluntary reporting system, and include only those seizures 
reported to EPIC by contributing agencies. Although reported seizures may not 
fully refl ect total seizures nationwide, a number of steps were taken to ensure, as 
far as possible, the use of reliable data (see below). 
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DATA PREPARATION
Working with EPIC personnel, a series of steps were used to organize the CLSS 
data for analysis. First, ten states were excluded either due to known problems with 
data reporting or low seizure frequency due to regional location (primarily New 
England states) where the methamphetamine STL problem did not appear to have 
yet signifi cantly developed (Connecticut, Delaware, Massachusetts, Maryland, 
Maine, New Hampshire, New Jersey, Rhode Island, Texas, and Vermont). Second, 
a comparison of CLSS data with Community Oriented Policing Services (COPS) 
data was employed in order to evaluate CLSS data reporting quality. COPS data 
includes counts of the number of times toxic site clean-up funds from COPS are 
requested by a state. For calendar year 2006, the count of COPS requests per state 
was compared with the number of seizures reported in the CLSS data. As not every 
lab seizure would be expected to require clean-up funding, the number of CLSS 
seizures should approximately meet or exceed the number of COPS clean-up requests 
per state. Eight states do not primarily rely on COPS data for clean-up, or use COPS 
grants and thus were not compared (California, Hawaii, Kansas, Kentucky, Maryland, 
Missouri, North Dakota, and Washington). A minimum threshold of 75% agreement 
was used, and resulted in exclusion of an additional eight states (Alaska, Louisiana, 
Minnesota, New Mexico, South Carolina, Tennessee, Utah, and West Virginia). Thus, 
the following 32 states were retained for analysis because they would provide the 
most reliable data for comparison of state methamphetamine precursor policies and 
trends in STL seizures: Alabama, Arizona, Arkansas, California, Colorado, Florida, 
Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, 
Mississippi, Missouri, Montana, Nebraska, Nevada, New York, North Carolina, 
North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Virginia, 
Washington, Wisconsin, and Wyoming. 
Following state selection, CLSS data were sorted by lab capacity and lab type. 
Seizures of labs with production capacity of 10 pounds per cooking cycle or higher 
(termed “super labs”) were removed. Data were then organized by lab type to ensure 
that only methamphetamine-related lab seizures were included (anhydrous ammonia, 
hydriodic acid, ice conversion, methamphetamine, methcathinone [included as it 
requires the same ephedrine/pseudoephedrine precursors as methamphetamine], 
P2P/methylamine, tablet extraction, and urine extraction labs) (Amera-Chem, Inc., 
2004). A total of 39,923 seizure incidents during 2004 through 2006 in the 32 states 
remained for analysis.
Next, the coded state precursor policy data were merged with the seizure incident-
level CLSS data. An indicator variable was created to identify if a seizure occurred 
at any point following the relevant state’s policy change effective date. The decision 
to create an “any” lag variable was predicated on the anecdotal evidence indicating 
258 JOURNAL OF DRUG ISSUES
MCBRIDE, TERRY-MCELRATH, CHRIQUI, O’CONNOR, VANDERWAAL, MATTSON 
an immediate impact of state laws on reductions in STL seizures as well as evidence 
from the relationship between other types of drug and substance control policies 
and behavior change that indicated both immediate and intermediate (3-years or 
less) impacts on behavior change (Bundy, 2004; Colby, 2004; Fuller, Rieckmann, 
McCarty, Ringor-Carty, & Kennard, 2006; Levy, 2007; Rutledge, 2004; Wright, 
2004). Data were then aggregated into bi-monthly counts of STL seizures per state, 
resulting in an N of 2,304 (72 cases per state). Each case (i.e., each bi-monthly count 
of STL seizures per state) was then coded as being pre/post policy implementation. 
At least 50 percent of the seizures in the relevant bi-monthly time period were 
required to have occurred after the specifi c policy was implemented in order to be 
coded as post-policy implementation.
CONSTRUCTS AND MEASURES
OUTCOME MEASURE
For all analyses, the outcome measure was the bi-monthly count of STL seizures 
per state (described above). Given the strong positive skew of the measure, analytical 
models utilized natural log transformation of the original variable (a constant of 1 
was added to all cases before conducting the transformation, as some cases had 0 
seizures).
INDEPENDENT MEASURES: STATE POLICY TYPES AND STATE POLICY CHANGE DATE INDICATOR
Based on initial exploratory models, we chose to focus on four policy areas 
that were most likely to relate to STL seizure counts: (a) retail transaction quantity 
restrictions, (b) sales environment restrictions, (c) purchase and possession 
penalties, and (d) agency responsible for enforcing precursor policies. Individual 
policies within each of the four areas noted above were then explored for evidence 
of relationships with STL seizure counts. Results showed that states appeared to 
enact bundled policy provisions. For example, if a state enacted a policy requiring 
photo identifi cation (ID) when purchasing products containing pseudoephedrine or 
ephedrine, it was also likely to require that the precursors be available only behind 
the counter. After further examining the data, the following state policy types were 
identifi ed:
Clerk intervention and quantity/packaging restrictions (separate variables for 
both ephedrine and pseudoephedrine): Clerk intervention was defi ned as at least 
one of the following: product located behind counter, buyer signature required in 
a separate clerk logbook, photo ID required, sales to minors prohibited. Quantity/
packaging restrictions were defi ned as “any” restrictions. These variables were 
combined to form one four-level ordinal measure: 0=neither clerk intervention nor 
quantity/packaging restrictions; 1=no clerk intervention, but have quantity/packaging 
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restrictions; 2=have clerk intervention, but no quantity/packaging restrictions; 
3=have both clerk intervention and quantity/packaging restrictions.
Buyer purchase offense severity (separate variables for both ephedrine and 
pseudoephedrine): 0=non-crime, 1=crime (misdemeanor or felony).
Specifi cation of sales regulatory/enforcement agency: 0=no such specifi cation; 
1=agency specifi ed. For example, the policy might state that the state police were 
responsible for monitoring and enforcing sales violations.
We examined the effective dates by state for the policy types identifi ed above. 
Some states had pre-existing policies (effective prior to January 2004). Almost all 
states that enacted policy change between January 2004 and October 1, 2005 did 
so at a single point in time, most often combining more than one policy type and 
sometimes specifying the same policy provisions for both pseudoephedrine and 
ephedrine (only Wisconsin had two separate methamphetamine precursor policy-
related effective dates). Because of this complex state policy change environment, 
it was not possible to meaningfully model differences in individual policy type 
change dates. Thus, a single dichotomous indicator variable was created identifying 
each case of bi-monthly seizures as pre- or post-policy change effective date (for 
Wisconsin, the fi rst policy change date was used; the second effective date occurred 
only 45 days following the fi rst, and no substantive differences were found based 
on use of the fi rst or second change date). Cases occurring prior to the effective date 
were coded as 0, while cases were coded as 1 if at least 50 percent of the seizures 
occurred following the state policy change effective date.
A 13-level categorical variable was then created to identify states by type of 
policy change approach (see the Results section for further details). This variable 
was created to examine the robustness of results for the state policy change indicator 
across policy environment change types. 
INDEPENDENT MEASURES: FEDERAL POLICY INDICATORS
O’Connor and colleagues (O’Connor, Chriqui, & McBride, 2006) point out that 
policy activity directed at limiting access to methamphetamine precursor chemicals 
has not been limited to the state level. While a variety of historical federal policies 
have been in place, two specifi c policy provisions took effect during our study time 
period (i.e., 2004-2006) that could be expected to relate directly to STL seizure 
rates in the current models. These policies were both included in the Combat 
Methamphetamine Epidemic Act (Combat Methamphetamine Epidemic Act , 
2006) (see Appendix A for citation information and effective dates for both state 
and federal policies):
Federal purchase quantity limits: 0=prior to policy; 1=restrictions for non-liquid 
pseudoephedrine sold to individuals (effective April 8, 2006).
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Federal clerk intervention requirement: 0=prior to policy; 1=requirements to place 
methamphetamine precursor products behind the counter or in locked cabinets at 
the point of sale, photo ID, retailer logbook of all sales, and staff training (effective 
September 30, 2006).
It is important to note that federal policy did not preempt more restrictive state 
policies. However, in recognition of the possible impact of federal laws on the 
relationship between state methamphetamine precursor laws/regulations and STL 
seizures, analytical models included indicators variables for both federal provisions 
(based on their effective dates) identifi ed above. Clearly, only a very small number 
of cases in the current study occurred following the federal clerk intervention 
requirement. Thus, models controlled for the federal clerk intervention policy change 
indicator, but results will not be reported because estimates are not expected to be 
suitably reliable. In contrast, as 24 percent of cases in the current study occurred 
following the implementation of the federal purchase quantity limits (see Table 1), 
obtained estimates will be reported for this policy measure.
ANALYTICAL MODELS
Given the panel nature of the data and the pre-existing trend in STL seizures, 
analyses were conducted using Stata v10.1 and specifying xtregar to fi t random 
effects cross-sectional time-series regression models with a fi rst-order autoregressive 
disturbance using the GLS estimator (StataCorp LP, 2007). Analyses to answer 
the fi rst research question (looking for evidence that STL seizure rates decreased 
signifi cantly following state and federal policy changes) were modeled using 
variations of the following equation: 
where y = the number of seizures for state i at time t; υ is the state-specifi c 
residual, and ε is the fi rst-order autoregressive disturbance term 
Models were estimated in the following order: Model 1 included only the state policy 
change indicator; Model 2 added both federal policy change indicators; Model 3 
added state fi xed effects. A second series of analyses were then estimated using Model 
3 but grouping by state policy bundle type (i.e., testing to see if the policy change 
indicators remain signifi cant across policy bundle types). Following this, all models 
were again estimated restricting the data to include only time periods occurring 
prior to October 1, 2005, in order to avoid time periods during which additional 
state policies may have been implemented but which were not captured due to the 
October 1, 2005 state policy data collection cut-off (these models necessarily did 
not include federal policies, which had not yet been implemented). 
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Analyses to answer the second research question (if differences existed between 
states in the relative effectiveness of specifi c precursor policy environment) 
were estimated using a similar equation to that specifi ed above (Model 3) but 
substituting the following sets of policy environment predictors for the dichotomous 
state change indicator: (a) ephedrine clerk intervention and quantity packaging 
restrictions, ephedrine buyer purchase offense severity, regulatory/enforcement 
agency specifi cation; or (b) pseudoephedrine clerk intervention and quantity 
packaging restrictions, pseudoephedrine buyer purchase offense severity, regulatory/
enforcement agency specifi cation. 
RESULTS
As noted previously, a total of 2,304 cases representing bi-monthly seizure counts 
for 32 states were included in analyses. Table 1 indicates that over the 2004-2006 
period of study, the mean number of seizures per bi-monthly time period was 17.3 
(overall standard deviation (SD) 24.4), with a range of 0 to 213. Both between- 
and within-state variance were signifi cantly greater than zero (SDbetween=20.4; 
SDwithin=13.8); indicating that seizure rates differed strongly both between states 
and within states over time. This is presented graphically in Figures 1 and 2. Figure 
1 shows that, for all states, STL bi-monthly seizure counts dropped from a high 
of 1,117 in early 2004 to 212 at the end of December 2006. The strong decreasing 
trend is likely attributable to a variety of factors including social trends and pre-
existing policy differences. Analyses discussed below investigated if policy changes 
implemented during the study time period contributed signifi cantly to seizure rate 
trends.
Figure 2 shows the strong differences in STL seizure rates between those states 
with and without any state methamphetamine precursor policy changes during the 
time period of the current study. As noted in the Introduction, STL manufacture of 
methamphetamine has experienced signifi cant geographic variance. It is important 
to note that public safety and health consequences often precede (and result in) 
legislative action. Figure 2 shows that states with methamphetamine precursor 
policy changes had signifi cantly higher levels of STL seizures. At least in the case 
of methamphetamine precursor policy, change appears to have been driven by the 
need to address existing problems related to STL methamphetamine manufacture 
(vs. implementing policy as a purely preventive measure). 
The overall distribution of cases by policy change date indicator can be found 
in Table 1. Thirty-nine percent of cases occurred following the fi rst or only state 
policy change effective date (between January 2004 and October 1, 2005). As noted 
previously, Wisconsin was the only state to have a second policy change effective 
date (only 2% of cases occurred following this date). Twenty-four percent of cases 
occurred following the effective date of federal purchase quantity limits on non-
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TABLE 1. DESCRIPTIVES
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 FIGURE 1. TOTAL METHAMPHETAMINE-RELATED SMALL TOXIC LAB SEIZURES IN 32 
RETAINED STATES, 2004-2006
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liquid pseudoephedrine sold to individuals, and eight percent occurred following 
the effective date of federal clerk intervention policy.
Table 2 presents the types of state policy changes grouped in change type bundles 
that were observed in the current study, as well as showing the mean seizures and 
number of states associated with each bundle group. Seven states had no pre-existing 
policies and did not implement any prior to October 1, 2005. Two states (California 
and Arizona) had pre-existing policies, but did not change or add policies between 
FIGURE 2. TOTAL METHAMPHETAMINE-RELATED SMALL TOXIC LAB SEIZURES FROM 
2004-2006 IN RETAINED STATES WITH NO STATE PRECURSOR POLICIES 
(AS OF OCTOBER 1, 2005) VERSUS STATES WITH POLICIES BECOMING EFFECTIVE 
BETWEEN JANUARY 1, 2004 AND OCTOBER 1, 2005
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January 2004 and October 1, 2005. Two additional states (Alabama and Mississippi) 
implemented changes in all included policies between January 2004 and October 1, 
2005. The remaining 21 states implemented a change in at least one but not all of the 
precursor policies between January 2004 and October 1, 2005. It is important to note 
that some of these states had at least one implemented policy prior to January 2004.
The overall distribution of cases by the type of state policy environment can 
be found in Table 1. Over half of all cases occurred when a state had neither clerk 
intervention nor quantity/packaging restrictions for either ephedrine (64%) or 
pseudoephedrine (55%) by the October 1, 2005 state policy cut-off date. Just over 
10 percent of cases occurred in a policy environment where quantity/packaging 
restrictions were in place without clerk intervention (11% for ephedrine; 13% for 
pseudoephedrine); very few cases occurred in policy environments where clerk 
intervention was in place but not quantity/packaging restrictions (4% for both 
ephedrine and pseudoephedrine). A higher percentage of cases occurred in policy 
environments where both clerk intervention and quantity/packaging restrictions 
were in place for pseudoephedrine (28%) than ephedrine (20%). Approximately 23 
percent of cases occurred in policy environments where the penalty for purchasing 
pseudoephedrine or ephedrine was classifi ed as a crime (either misdemeanor or 
felony). Finally, 31 percent of cases occurred where states had specifi ed an agency 
for regulatory/enforcement activities regarding methamphetamine precursor sales. 
TABLE 2. STATE METHAMPHETAMINE PRECURSOR POLICY CHANGE GROUPINGS, 2004–2006
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PRE- AND POST-PRECURSOR POLICY STL SEIZURE RATE CHANGES
Table 3 shows results of models examining rates of STL seizures for all 
32 included states by both state and federal precursor policy implementation 
indicators. Rates of STL seizures decreased signifi cantly following state policy 
change implementation, and this decrease was signifi cant after controlling for both 
federal policy implementation as well as state fi xed effects (see results for Model 
3). Results also show that the federal purchase quantity policy implementation date 
was also independently associated with decreased seizure rates both before and after 
controlling for state fi xed effects (see results for Model 3). When analyses were 
re-estimated restricting the sample to only cases occurring prior to the October 1, 
2005 policy coding cut-off date, the direction and signifi cance level of results for 
both state and federal policy change indicators did not change (results not shown). 
Table 4 presents results of analyses seeking to explore if the signifi cance of the 
state policy change date was robust across different state policy change approaches. 
TABLE 3. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE 
SMALL TOXIC LAB SEIZURE RATES BY ANY POLICY CHANGE, 2004–2006 
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TABLE 4. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE 
SMALL TOXIC LAB SEIZURE RATES BY ANY STATE POLICY CHANGE, MODELED SEPARATELY 
BY POLICY CHANGE BUNDLE, 2004–2006
See page 268 for Table 4 notes.
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Notes: All models controlling for federal clerk intervention change indicator and state fi xed effects 
(results not reported). Outcome is the natural log of bi-monthly counts of STL seizures, with a 
constant of 1 added to all cases.
A. No changes; no pre-existing policies
B. No changes; pre-existing policies
C. Pseudoephedrine clerk intervention and quantity/packaging restriction policy change
D. Pseudoephedrine clerk intervention and quantity/packaging restriction policy change; 
specifi cation of regulatory/enforcement agency policy change
E. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction policy 
change
F. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction 
changes; specifi cation of regulatory/enforcement agency policy change
G. Pseudoephedrine and ephedrine clerk intervention and quantity/packaging restriction 
change; pseudoephedrine and ephedrine purchase severity policy change
H. Changes in all noted policies
I. Category includes 4 states, each of which was the only state to implement their specifi c type 
of policy change. Policy changes included:
 (1) specifi cation of regulatory/enforcement agency; 
 (2) pseudoephedrine clerk intervention and quantity/packaging restriction; 
pseudoepherine purchase severity; specifi cation of regulatory/enforcement agency;
 (3) pseudoephedrine and ephedrine clerk intervention and quantity/packaging 
restriction; ephedrine purchase severity;
 (4) ephedrine clerk intervention and quantity/packaging restriction; specifi cation of 
regulatory/enforcement agency
*p<.05; **p<.01; ***p<,001
a Restrictions for non-liquid pseudoephedrine sold to individuals.
ρar: Estimated autocorrelation coeffi cient.
σu: State-level standard deviation (between states)
σe: Standard deviation of bi-monthly time periods (within states)
ρfov: Fraction of variance between states
TABLE 4. TIME SERIES REGRESSION RESULTS FOR DIFFERENCES IN METHAMPHETAMINE 
SMALL TOXIC LAB SEIZURE RATES BY ANY STATE POLICY CHANGE, MODELED SEPARATELY 
BY POLICY CHANGE BUNDLE, 2004–2006 (CONTINUED)
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TABLE 5. BETWEEN-STATE DIFFERENCES IN METHAMPHETAMINE-RELATED SMALL TOXIC LAB 
SEIZURE RATES BY SPECIFIC PRECURSOR POLICY ENVIRONMENTS, 2004–2006
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Separate models were estimated for all policy change environments in which at 
least two states utilized the same change bundle. As single-state models cannot be 
estimated using a cross-sectional time series model, the four states that implemented 
unique policy change approaches were combined in one model. Results show that 
regardless of the state policy change bundle, STL seizure rates decreased signifi cantly 
following state policy change implementation. Analyses were re-estimated in models 
restricting the sample to only cases occurring prior to the October 1, 2005 policy 
cut-off date. While the signifi cance level for Policy Bundle E dropped from p<.001 
to p<.01 in these models, the direction and signifi cance level of all other results 
did not change.
Table 4 shows that the signifi cance of the implementation of federal policy 
did vary across the different state policy groupings. Implementation of federal 
quantity restrictions were not related to seizure rates in the following state groups: 
(1) three states implementing changes in pseudoephedrine clerk intervention and 
quantity/packaging restrictions, as well as specifi cation of regulatory/enforcement 
agency; (2) three states implementing changes in pseudoephedrine and ephedrine 
clerk intervention and quantity/packaging restrictions, as well as specifi cation of 
regulatory/enforcement agency; (3) two states implementing changes in all noted 
policies. 
BETWEEN-STATE DIFFERENCES IN STL SEIZURE RATES BY POLICY ENVIRONMENT
The results of the analyses presented above indicate that statistically signifi cant 
reductions in STL seizures occurred following the implementation of policies 
directed at controlling access to products containing the methamphetamine precursor 
chemicals ephedrine and pseudoephedrine. We now turn to focusing on between-
state differences in STL seizure rates by overall policy environment with models 
controlling for the a priori highly signifi cant differences in STL seizure rates between 
states. Results of these analyses are presented in Table 5.
States with any type of clerk intervention or quantity/packaging restrictions 
showed lower rates of STL seizures than did states without such policies (for both 
ephedrine and pseudoephedrine). While the specifi c clerk intervention approach 
taken for ephedrine did not appear to signifi cantly relate to seizure rates, the 
same was not true for pseudoephedrine. STL seizure rates were higher in states 
with pseudoephedrine quantity/packaging restrictions only compared to states 
with quantity/packaging restrictions combined with clerk intervention provisions 
(coeffi cient 0.2249; p<.05; data not shown). No difference in seizure levels between 
states was observed based on whether or not the state had criminal penalties for 
purchasing violations of either ephedrine or pseudoephedrine precursor policies. 
However, STL seizure rates were signifi cantly lower in states that specifi ed an 
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agency for regulatory/enforcement responsibilities. Federal policy implementation 
continued to be related to decreased STL seizures.
DISCUSSION
In the last few decades, there has been considerable discussion regarding the 
specifi c roles of federal and state governments in establishing policy related to the 
public’s health, including policy related to substance use. Some perceive that such 
policy is exclusively a federal affair, while others believe state governments should 
be the main actors in such policy development. One area in which both states and 
the federal government have had signifi cant recent policy development activity deals 
with reducing the signifi cant criminal justice and public-health concerns resulting 
from STL methamphetamine production and use.
The data documents that states took a wide variety of approaches toward reducing 
access to the methamphetamine precursor chemicals ephedrine and pseudoephedrine. 
From January 1, 2004 through October 1, 2005, 72 percent (23) of the 32 states 
included in the current study implemented some type of change in policy focusing 
on either (a) controlling the quantity of ephedrine/ pseudoephedrine-containing 
product sales, (b) the required form (if any) of clerk intervention at the point of 
purchase, (c) the defi nition of precursor policy purchasing violations as a crime, 
or (d) specifying a regulatory agency to oversee enforcement of the state’s policy. 
All of the state policy changes noted above occurred prior to changes in federal 
policy specifying non-liquid pseudoephedrine quantity limits as well as defi ning 
methamphetamine precursor chemical clerk intervention policies. Such variance 
over time allowed us to develop models aimed at examining pre/post policy changes 
in methamphetamine STL seizures, as well as comparisons of STL seizure rates 
between methamphetamine precursor policies.
This paper set out to examine two research questions: (1) Is there evidence that 
STL seizure rates decreased signifi cantly following state and federal policy changes 
implemented between January 2004 and October 1, 2005? (2) Is there evidence that 
differences exist between states by type of specifi c methamphetamine precursor 
policy environment? The results from the analyses indicate that the answers to 
both research questions are affi rmative. STL seizure rates decreased signifi cantly 
following state and federal policy change effective dates, both overall and across 
different state policy change groups. This consistent decline in methamphetamine 
STL seizures soon after the implementation of state and federal precursor policies 
is a fi nding consistent with media reports (Associated Press, 2006), qualitative 
research (VanderWaal et al., 2008), and conclusions by the U.S. Department of 
Justice (NDIC, 2005). 
Results also indicated that some state policies related strongly to decreases in 
STL seizures (clerk intervention and quantity/packaging restrictions; specifi cation 
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of a regulatory/enforcement agency) while others (purchase penalty severity) did 
not. As discussed in the introduction, there is literature that indicates a decrease in 
STL seizures after the implementation of general policies attempting to limit access 
to methamphetamine precursor chemicals. However, little research has focused on 
specifi c policy elements. In this paper, within-state analyses found that states which 
restricted the quantity of ephedrine/pseudoephedrine sales, or required some form of 
clerk intervention, were more likely to report signifi cant reductions in STL seizures 
following policy implementation. This suggests that restricting precursor chemicals 
via quantity restrictions likely relates to less availability, which in turn relates to 
a reduced ability to manufacture methamphetamine in STLs. In pseudoephedrine 
models, combining quantity restrictions with the requirement for some type of 
clerk intervention (requiring photo ID or locating the product behind the counter) 
was associated with signifi cantly reduced STL seizures compared with quantity/
packaging restrictions alone. This fi nding suggests that for pseudoephedrine--the 
substance with higher direct consumer access in the local retail environment--clerk 
intervention plays a key role in reducing access for STL manufacturers. 
One of the policies examined in quantitative models was whether or not 
states identifi ed an agency that was responsible for enforcing/regulating enacted 
methamphetamine precursor policies. As of October 1, 2005, only 11 of the 32 
retained states’ policies identifi ed a regulatory agency responsible for enforcement 
and implementation. Identifi cation of an agency to oversee the implementation of 
their methamphetamine precursor sales policies was associated with signifi cant 
reductions in STL seizures. The data suggest it may not be suffi cient merely 
to enact policies that restrict access to dangerous chemicals; mechanisms for 
reporting violations and regulating compliance must also be in place. There is some 
indication in the media (Bovett, November 16, 2010:A31) and in discussions with 
law enforcement, that due to the lack of precursor sales tracking in many states, 
“smurfi ng” (users going from store to store and buying the limit of pseudoephedrine 
in each store) continues at a relatively high rate.
One of the most common policies used in attempts to reduce the production, 
distribution or use of illegal drugs involves the enactment of severe criminal 
penalties. This approach is based on classic deterrence theory that argues that if 
penalties are suffi ciently severe, the behavior will be less likely to occur (Mendes 
& McDonald, 2001). However, results show that, controlling for the relative 
impact of other policies, criminal penalties for purchase were not associated with 
signifi cantly reduced STL seizure rates. This may suggest that, at least in regards 
to STL seizures, penalty policies for purchase do not appear to have as much of 
a deterrent effect on STL rates as do policies restricting and enforcing access to 
ephedrine/pseudoephedrine. 
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 Perhaps one of the most important fi ndings in the current paper is that, overall, 
both state and federal policies matter. In almost all of the analytical models, 
signifi cant decreases in STL seizure rates were associated with the implementation 
date of the federal policy focusing on non-liquid pseudoephedrine quantity limits 
after controlling for state policy. Alternately, the implementation date of state 
precursor policy changes was also associated with decreases in STL seizure rates after 
controlling for federal policy. It is important to remind readers that changes in state 
policy occurring after October 1, 2005, were not included in analytical models. Thus, 
it is possible that fi ndings related to federal policy may, in some way, be associated 
with unmeasured state policy changes. However, the data indicate that both federal 
and state policies are an important part of a comprehensive approach directed at 
reducing the consequences and harms associated with illicit drug production and 
use. Federal law may help prevent the purchasing of large quantities of precursor 
chemicals in one state and then, following transporting of the materials across state 
lines, manufacturing methamphetamine in states with existing precursor policies. 
Further, while federal law was less stringent that some state policies, it may have 
also provided an important minimum purchasing standard and penalties for states 
that had not yet enacted any precursor laws.
The analyses presented in this paper suggest that both the states and the 
federal government took a measured and complex approach to reducing STL 
methamphetamine production. Purchase quantity controls, combined with clerk 
intervention and having a regulatory agency responsible for policy implementation 
and monitoring of purchases, consistently related to reductions in STL lab seizures in 
both within- and between-state analyses. These data suggest that there is not a simple 
approach to addressing an issue such as the domestic production of methamphetamine 
in STLs. However, a combination of policies appears to have related to signifi cant 
reductions in the domestic STL production of methamphetamine. It remains to be 
seen if this reduction in STL labs is related to a reduction in methamphetamine use, 
quality, or purity (Royal Canadian Mounted Police, 2001). Further, it is unknown 
if these observed policy relationships will continue over time or if STL operators 
will eventually resume prior production levels. Such an increase might well occur 
if resources are not available to continue active efforts to reduce STL production, or 
if existing policies are not enforced through a regulatory agency using an integrated 
data system capable of recording and tracking precursor purchases. 
The fi ndings of this study should be considered within their limitations. The 
source for the outcome measure for these analyses is the CLSS data which, as 
noted previously, are voluntarily reported data. Thus, CLSS data are not necessarily 
reported with equal accuracy across states or within states across time. However, the 
CLSS data remain the only extant data source on US illicit drug laboratory seizures, 
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and are a primary source of information for the US Department of Justice (Dobkin 
& Nicosia, 2009). As the authors worked closely with EPIC personnel and COPS 
comparisons to include only those states with the highest data quality, the resulting 
data is believed to be the best currently available. Readers should also recognize 
that the analyses focused only on how the examined policies relate to STL seizure 
reductions. Analyses examining how such policies relate to the prevalence of 
methamphetamine use in the community, or to reductions in costs borne by local, 
state, and federal governments resulting from STL clean-up efforts and/or hospital 
and treatment costs, were not within the scope of these analyses. It is also important 
to note that Dobkin and Nicosia (2009) indicated that methamphetamine markets 
have tended to recover fairly rapidly from attempts to interrupt supply. This may 
suggest the continued importance of further policy developments to address changing 
production markets. For example, recent epidemiological evidence indicates a shift in 
local methamphetamine production to what is known as the “one pot” or “shake and 
bake” method. This method involves smaller laboratories and lessened amounts of 
precursors (and smaller quantities of produced methamphetamine) thereby lessening 
the likelihood of detection (National Institute on Drug Abuse, 2010). Further, state 
policies enacted and effective after the October 1, 2005 policy cut-off date were 
beyond the scope the analyses, but would prove important in future research as 
would analyses of longer-term impacts of the policies on reductions in STL seizures. 
Small toxic labs present signifi cant environmental and health-related dangers and 
costs to communities. Data presented in this paper indicate that many states have 
developed policies that do, indeed, appear to have related to rapid and signifi cant 
declines in the production of methamphetamine in STLs. The data also suggest that 
a comprehensive federal and state approach that includes designated regulatory 
agencies that can enforce precursor policies focusing on quantity controls, clerk 
intervention, and a regulatory system than monitors precursor chemical purchases 
are crucial policy elements in efforts to reduce the number of STLs that manufacture 
methamphetamine in the US and their associated harms.
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